These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 13552741)

  • 1. Antiphlogistic action of histamine-liberator compound 48/80, some antihistaminics and antirheumatics.
    KRAMER M
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1958; 233(2):125-33. PubMed ID: 13552741
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antiphlogistic effect of histamine liberator 48/80 & various antihistaminics].
    KRAMER M
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1957; 232(1):319-20. PubMed ID: 13526877
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of antihistaminics on the permeability-increasing action of histamine and histamine liberator 48/80 in guinea pigs].
    ALBERTY J; TAKKUNEN R
    Arch Int Pharmacodyn Ther; 1956 Dec; 108(3-4):366-77. PubMed ID: 13412171
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of a histamine liberator (compound 48/80) on methylcholanthrene induced skin carcinoma in mice.
    DILLON T; GOTH A; MONTGOMERY PO
    Tex Rep Biol Med; 1956; 14(4):432-9. PubMed ID: 13391741
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the mechanism of action of compound 48/80. I. Vital microscopic studies of vascular reactions in untreated guinea pigs & rats & those pre-treated with hormones & antihistaminics after local administration of 48/80 & reserpine].
    SCHEIFFARTH F; ZICHA L; GEMAHLICH M; SCHMID E
    Allerg Asthma (Leipz); 1958; 4(2):80-7. PubMed ID: 13582820
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mechanism of action of anaphylatoxin. I. Behavior of guinea pigs in anaphylatic shock after pretreatment with a histamine-liberator].
    SCHEIFFARTH F; FRENGER W; GEMAHLICH M
    Z Immun exp ther; 1958 Mar; 115(3):224-7. PubMed ID: 13558328
    [No Abstract]   [Full Text] [Related]  

  • 7. [The histamine-fixing capacity of the serum and articular fluid in rheumatic patients. (1st results)].
    PARROT JL; GALMICHE P; SAINDELLE A
    Rev Rhum Mal Osteoartic; 1961 Dec; 28():637-42. PubMed ID: 14038196
    [No Abstract]   [Full Text] [Related]  

  • 8. [The mechanism of action of histamine and antihistaminics].
    STERN P
    Med Pregl; 1954; 7(3):207-13. PubMed ID: 13235060
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacodynamic action of histamino-salicylic iontophoresis on the adrenals, in rheumatism].
    LANDA BACALLAO M; DE DIEGO CABALLERO ; ALVAREZ GUIN M; VALERDE MARTIN A
    Rev Med Cubana; 1955 Mar; 66(3):157-67. PubMed ID: 14385326
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combinations of antirheumatics].
    Jarløv N
    Ugeskr Laeger; 1971 Oct; 133(43):2124. PubMed ID: 5315951
    [No Abstract]   [Full Text] [Related]  

  • 11. [The role of histamine in the anaphylactic vascular skin reaction induced by chemical histamine liberator].
    ALBERTY J; TAKKUNEN R
    Int Arch Allergy Appl Immunol; 1957; 10(5):285-304. PubMed ID: 13474815
    [No Abstract]   [Full Text] [Related]  

  • 12. [Histamine therapy of rheumatic diseases].
    BIRO L
    Orv Hetil; 1951 Jul; 92(29):934-7. PubMed ID: 14863882
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental headache with endogeneous histamine; first results obtained by 48/80, a histamine-liberator drug, in the cephalic and peripheral circulatory systems of man.
    SICUTERI F; RICCI M; MONFARDINI R; FICINI M
    Acta Allergol; 1957; 11(3):188-92. PubMed ID: 13468941
    [No Abstract]   [Full Text] [Related]  

  • 14. The cardiovascular manifestations of rheumatic diseases.
    Goodson NJ; Solomon DH
    Curr Opin Rheumatol; 2006 Mar; 18(2):135-40. PubMed ID: 16462518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SYMPOSIUM ON INFLAMMATION AND ROLE OF FIBRIN IN THE RHEUMATIC DISEASES.
    GLYNN LE
    Bull Rheum Dis; 1963 Nov; 14():323-6. PubMed ID: 14060158
    [No Abstract]   [Full Text] [Related]  

  • 16. [Endocisternal introduction, in dogs, of a histamine liberator (48/80)].
    FLORIS E
    Boll Soc Ital Biol Sper; 1957; 33(1-2):32-3. PubMed ID: 13446181
    [No Abstract]   [Full Text] [Related]  

  • 17. The Walterinnesia toxin as a liberator of histamine from tissues.
    MOHAMMED AH; ZAKI O
    J Trop Med Hyg; 1957 Nov; 60(11):275-80. PubMed ID: 13482028
    [No Abstract]   [Full Text] [Related]  

  • 18. [Histamine liberator properties of a substitute butylamine, 1935 L. in rat].
    HALPERN BN; LIACOPOULOS-BRIOT M; NEVEU T; LIACOPOULOS P
    C R Seances Soc Biol Fil; 1957; 151(5):853-8. PubMed ID: 13500678
    [No Abstract]   [Full Text] [Related]  

  • 19. [Is disulfiram an endogenous histamine-liberator].
    TROQUET J
    C R Seances Soc Biol Fil; 1958; 152(11):1605-6. PubMed ID: 13639446
    [No Abstract]   [Full Text] [Related]  

  • 20. [Protective effect of histamine liberator 48/80 against fatal doses of arsenic compounds].
    HUKOVIC S; STERN P
    Chemotherapia (Basel); 1960; 1():392-8. PubMed ID: 13716737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.